Upsher-Smith Announces Development Agreement With Lundbeck

          Upsher-Smith Announces Development Agreement With Lundbeck

PR Newswire

MAPLE GROVE, Minn., Sept. 30, 2013

MAPLE GROVE, Minn., Sept.30, 2013 /PRNewswire/ --Upsher-Smith Laboratories,
Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to
the development of new treatments for diseases of the central nervous system,
today announced that its UK subsidiary, Proximagen Limited, has entered into a
preclinical development agreement with Denmark-based H. Lundbeck A/S
(Lundbeck) to further its research program related to protein kinase
inhibitors. This transaction is part of Upsher-Smith's long-term strategy to
advance its current product portfolio of branded drugs. Specific terms related
to the deal have not been disclosed.

(Logo: http://photos.prnewswire.com/prnh/20130520/NY17281LOGO )

"Upsher-Smith is pleased to announce today's development agreement with
Lundbeck. We are very impressed with the world-class research conducted by
Lundbeck and excited about the opportunity to bring a new therapy forward that
may benefit patients," said Mark Evenstad, President and Chief Executive
Officer of Upsher-Smith.

"Forming successful alliances is a key strategic objective for Lundbeck. We
share Upsher-Smith's commitment to develop therapies that may have the
potential to improve the lives of people living with challenging medical
conditions," said Ulf Wiinberg, Chief Executive Officer of Lundbeck.

About Upsher-Smith
Upsher-Smith, founded in 1919, is an independent and privately-owned specialty
pharmaceutical company headquartered in Maple Grove, Minnesota that focuses on
product growth and innovation for branded and generic pharmaceuticals.
Upsher-Smith has a particular focus on developing therapies to assist people
suffering from central nervous system diseases, and also markets products
relating to cardiology, dermatology, and women's health. For more
information, visit www.upsher-smith.com.



SOURCE Upsher-Smith Laboratories, Inc.

Website: http://www.upsher-smith.com
Contact: Elizabeth Likly, Kovak-Likly Communications, 203-762-8833,
elikly@klcpr.com
 
Press spacebar to pause and continue. Press esc to stop.